Chemours (CC) Beats Q4 Earnings Estimates

分组1 - Chemours reported quarterly earnings of $0.05 per share, exceeding the Zacks Consensus Estimate of breakeven, but down from $0.11 per share a year ago, representing an earnings surprise of +2,400.00% [1] - The company posted revenues of $1.33 billion for the quarter ended December 2025, aligning with the Zacks Consensus Estimate, but down from $1.36 billion year-over-year [2] - Chemours shares have increased approximately 79.4% since the beginning of the year, significantly outperforming the S&P 500's gain of 0.5% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is $0.20 on revenues of $1.43 billion, and for the current fiscal year, it is $1.70 on revenues of $6.04 billion [7] - The Zacks Industry Rank for Chemical - Diversified is currently in the bottom 23% of over 250 Zacks industries, indicating potential underperformance compared to higher-ranked industries [8] - The estimate revisions trend for Chemours was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, suggesting expected underperformance in the near future [6]